Dr Reddy�s Launches Cheaper Version of Antibiotic Avelox in US
Dr Reddy’s Laboratories said that after a nod from United States Food & Drug Administration has launched antibiotic Moxifloxacin Hydrochloride Tablets 400 mg in the US.
Dr Reddy’s Laboratories said that after a nod from United States Food & Drug Administration has launched antibiotic Moxifloxacin Hydrochloride Tablets 400 mg in the US.
The drug which is used to treat epilepsy is recalled under the “class-II” classification.
Amlodipine Besylate and Atorvastatin Calcium tablets are used to treat high blood pressure (hypertension) or chest pain (angina) are recalled under “class III” classification.
Hyderabad-based Dr Reddy's Launches Hair Growth Supplement
The supplement has a unique formula including grape seed extract containing potent antioxidants and key nutrients needed for maintaining healthy hair.
The supplement has a unique formula including grape seed extract containing potent antioxidants and key nutrients needed for maintaining healthy hair.
Indian Pharma Company, Dr Reddy�s, Introduces BP Tablets in US Market
On September 11th, Dr Reddy’s Laboratories, introduced Metoprolol Succinate ER (Extended-Release) tablets in 25 mg, 50 mg, 100 mg & 200 mg dosages, in the US market.
On September 11th, Dr Reddy’s Laboratories, introduced Metoprolol Succinate ER (Extended-Release) tablets in 25 mg, 50 mg, 100 mg & 200 mg dosages, in the US market.
FDA Issues a Warning to Dr Reddy�s Chemicals Unit in Mexico
The US Food and Drug Administration have issued a warning letter to Dr Reddy’s chemicals manufacturing facility, Industrias Quimicas Falcon de Mexico, located in Cuernavaca.
The US Food and Drug Administration have issued a warning letter to Dr Reddy’s chemicals manufacturing facility, Industrias Quimicas Falcon de Mexico, located in Cuernavaca.
